RxDoctor Payments Data

Melinda Salinas, PA

Physician Assistant · Corpus Christi, TXNPI 1376723585

Payments from drug & device makers

$3,025in general payments, 2019–2025

Across 202 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$722
  • Novo Nordisk$445
  • Merck$357
  • GSK$286
  • Amarin Pharma, Inc.$246
  • AbbVie$221
  • plus $749 from 14 others

What the payments were for

  • Food & beverage$3,018100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,025 in reported general payments places this provider in the 80th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$27,067
Medicare patients
118
Services billed
501

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate86$82,184
MounjaroTirzepatide39$48,555
EliquisApixaban34$38,314
JardianceEmpagliflozin32$35,555
TrulicityDulaglutide20$31,115
OzempicSemaglutide22$28,011
JanumetSitagliptin Phos/Metformin Hcl50$27,800
XareltoRivaroxaban23$21,941
LinzessLinaclotide29$18,016
MyrbetriqMirabegron17$14,006
FarxigaDapagliflozin Propanediol20$11,943
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$10,980
Fluticasone-SalmeterolFluticasone Propion/Salmeterol33$4,188
Atorvastatin Calcium453$3,565
Omeprazole175$3,538

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$357$109,984136 claims
Lilly USA, LLCMounjaro, Trulicity$722$79,67059 claims
PfizerEliquis$30$38,31434 claims
Novo NordiskOzempic$445$28,01122 claims
AbbVieLinzess, Synthroid$221$21,09268 claims
Astellas Pharma US IncMyrbetriq$18$14,00617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Corpus Christi

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →